Jul 10, 2023
This is a translation of the Swedish press release published 2023-07-10 The market preparations before the launch continues with regulatory processes, visits to the PAS-conference in Washington, increased protection for Neola® through a new U.S. patent and trademark...
Jul 5, 2023
In a new interview with Direkt Studios, CEO Hanna Sjöström talks about the market preparation work before launch of the company’s medical device, Neola®, for continuous lung monitoring of preterm born babies. See the interview below (in Swedish). The U.S. market is...
Jun 29, 2023
When Neola Medical launch the medical device Neola® for continuous lung monitoring of preterm born infants, the U.S. market will be the most important market. The company recently opened an office in Palo Alto, Silicon Valley – an important step in the market...
Jun 14, 2023
Press communication Lund, Sweden, June 14, 2023 This is a translation of the Swedish press release published 2023-06-14 Neola Medical AB (publ) announces today that the company, in addition to its headquarters in Lund, will increase the presence in the U.S. by an...
Jun 7, 2023
Neola Medical’s CEO Hanna Sjöström presented about the company at ABG Sundal Life Science Summit on May 31. In the presentation, Hanna talks more about the company, the technology used in the company’s medical device Neola®, and upcoming milestones. Read more about...
May 22, 2023
Neola Medical released the Q1 report for 2023 last week. At the same time as they create an interest among neonatal intensive care units around Europe, there is intensive focus on verification before clinical studies. BioStock contacted CEO Hanna Sjöström for a...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
